Infectious Disease Control APAC News & Press Release Distribution

Infectious Disease Control

All
Global

Qurient Co. Ltd. and TB Alliance Announce Exclusive License Agreement for Telacebec (Q203), a New Anti-Tuberculosis Agent

Landmark Agreement for New Tuberculosis Treatment SEONGNAM-SI, South Korea and NEW YORK, Feb. 3, 2023 /PRNewswire/ -- Qurient Co. Ltd. ("Qurient", KRX: 115180), a clinical-stage biotechnology company based inSouth Korea, and TB Alliance, a not-for-profit organization dedicated to the discovery, ...

2023-02-03 14:34 3261

Innovation Deficit: Funds for Neglected Diseases like TB are Falling Short

NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The 2022 G-FINDER Report, released today, reveals that for the year 2021, global funding for the development of critical new health technologies to overcome the world's deadliest neglected diseases remained woefully inadequate and largely stagnant. Specific...

2023-01-31 21:30 2480

Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic

HONG KONG, Jan. 31, 2023 /PRNewswire/ -- In response to the infection peak season of COVID-19 in rural areas that may be brought about by people returning home during Chinese New Year, Fosun Foundation announced on9 January 2023 the cooperation with Fosun Pharma and Genuine Biotech to donateRMB10...

2023-01-31 16:10 4352

Chula Medicine Reveals Detection of Latent Dementia

Thai Red Cross Emerging Infectious Diseases Health Science Center, Faculty of Medicine,Chulalongkorn University has researched a blood test for markers of Alzheimer's that can give a 10-year warning, so people can be prepared to slow down the development of dementia in old age. BANGKOK, Jan. 30,...

2023-01-30 11:01 5141

Chula Medicine Reveals Detection of Latent Dementia

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster

GAITHERSBURG, Md., Jan. 18, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that partner SK bioscience has received expanded manufacturing and marketing...

2023-01-18 21:00 4009

CGTN: China's COVID-19 vaccines proven safe, effective by trials and data

BEIJING, Jan. 17, 2023 /PRNewswire/ -- COVID-19 vaccines produced in China have been proven to be safe and effective by clinical trials and real-world data. The vaccines have helped save people inChina and around the world, which is an irreversible accomplishment and cannot be challenged by denia...

2023-01-17 23:50 3582

CGTN: China protects lives, shares experience in global COVID-19 fight

BEIJING, Jan. 16, 2023 /PRNewswire/ -- Chinese people are embracing a bustling winter after the country downgraded its COVID-19 management policies. It's a breakthrough in the country's three-year fight against the pandemic, but challenges still lie ahead. Along the journey, China went all out...

2023-01-16 07:29 3840

CGTN: TCM continues to play significant role in treating COVID-19

BEIJING, Jan. 11, 2023 /PRNewswire/ -- Traditional Chinese Medicine (TCM) has been playing an important role inChina's fight against COVID-19. As China is shifting the focus of its COVID-19 response from preventing infections to protecting people's health and preventing severe cases, the unique...

2023-01-11 23:09 4629

CGTN: China downgrades COVID-19 rules as nation readies for normal life

BEIJING, Jan. 9, 2023 /PRNewswire/ -- China put its downgraded COVID-19 measures into force on Sunday as the nation began to resume normal life after three years of strict pandemic management. The nation reopened its border p...

2023-01-09 10:42 4257

CGTN: China downgrades COVID-19 rules as nation readies for normal life

China welcomes first arrivals following downgraded COVID management

BEIJING, Jan. 9, 2023 /PRNewswire/ -- A report from People's Daily: The first flights underChina's new COVID-19 management for international travelers arrived at airports in southChina's Guangdong province on Jan. 8, according to the national customs authority. Over 380 passengers were aboard tw...

2023-01-09 07:40 2924

CGTN: China's preparedness for adjusting its COVID-19 policies

BEIJING, Jan. 5, 2023 /PRNewswire/ -- Since China prioritized its COVID-19 response from the dynamic zero-COVID policy, some Western media and intellectuals have been questioningChina's "preparedness" of making the change. Preparedness can ...

2023-01-05 04:07 3241

CGTN: China's preparedness for adjusting its COVID-19 policies

CGTN: China's dynamic zero-COVID policy sets the foundation for reopening

BEIJING, Jan. 5, 2023 /PRNewswire/ -- China has adjusted its response to COVID-19 prevention and control in recent weeks. It announced it will downgrade COVID-19 management from Class A to Class B infectious disease while resuming passport, visa issuance and easing border-entry policies starting ...

2023-01-05 04:05 3578

CGTN: China's dynamic zero-COVID policy sets the foundation for reopening

China's optimization of control measures lays solid foundation for COVID-19 response

BEIJING, Jan. 4, 2023 /PRNewswire/ -- A report from People's Daily: Local authorities and relevant departments inChina have been making unremitting efforts recently to ensure the supply of medical resources, satisfy the demand for medicines and focus on the prevention and treatment of high-risk g...

2023-01-04 15:39 2994

Everest Medicines Announces New Strategic Plans, Reinforcing Transformation into a Fully Integrated Biopharmaceutical Company

--Focus on renal disease and mRNA platform portfolios-- --Build out commercialization capabilities in preparation for the potential approval and launch of Nefecon and Xerava inChina in 2023-- --Leverage both in-house discovery and strategic business development to establish industry leadership ...

2023-01-03 16:00 4629

CGTN: China monitors coronavirus mutations to adjust COVID-19 response

BEIJING, Jan. 3, 2023 /PRNewswire/ -- With China loosening its COVID-19 restrictions, some experts have expressed concern thatChina's relaxation of COVID-19 limitations will enhance the likelihood of the virus mutating. "It is a worry," said CNN, citing William Schaffner, professor at the Divisi...

2023-01-03 08:27 2836

CGTN: Xi Jinping salutes ordinary people's extraordinary efforts in New Year Address

BEIJING, Jan. 1, 2023 /PRNewswire/ -- From medical professionals to delivery men and women, from community workers to next-door neighbors, ordinary Chinese people are doing their best and lending a hand to help others cope with the latest waves of COVID-19 infections in the country. &amp...

2023-01-03 07:52 2776

CGTN：How do emergency wards in China cope with increasing COVID patients?

BEIJING, Jan. 3, 2023 /PRNewswire/ -- Ninety-year-old Qu Fucheng was waiting for his COVID-19 treatment in Wuhan Zhongnan Hospital when his son realized how crowded the emergency department was. "My father was in very critical ...

2023-01-03 06:54 3090

CGTN：How do emergency wards in China cope with increasing COVID patients?

Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza Vaccine Candidates

GAITHERSBURG, Md., Dec. 31, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the initiation of a Phase 2 trial for its COVID-19-Influenza Combination (CI...

2022-12-30 21:00 4911

Grand Pharma Announces Successful Clinical Progress of its Oral 3CL Protease Inhibitor GS221 Against COVID-19

* GS221 has conducted 3 clinical trials. Current results of clinical trials show favorable safety and tolerance in the subjects. After administration, the patients showed trends of improvement of clinical symptoms, shortening time for negative nucleic acid test, and rapid decline of viral load;...

2022-12-30 13:23 4121

CGTN: Vitality under COVID-19: China's smart ports aid increased throughput

BEIJING, Dec. 29, 2022 /PRNewswire/ -- China's Qingdao Port, a subsidiary of Shandong Port Group and the second-largest foreign trade port in eastChina's Shandong Province, has seen an increase in anchorage rotations of very large container ships, according to China Media Group. The port has han...

2022-12-29 11:55 8337

1 ... 5 6 789 10 11 ... 29